Stockreport

Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount? [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Regeneron Pharmaceuticals' US$994 share price signals that it might be 48% undervalued Analyst price target for REGN is US$1,042 which is 45% below our fair value est [Read more]